INDUSTRY UPDATE


New technologies change glaucoma treatment paradigm

【2020-3-6】Noncontact selective laser trabeculoplasty, a drug-eluting contact lens and a sustained release therapeutic under development may ...

查看详情
Harvard Business Review: What Coronavirus Could Mean for the Global Economy

【2020-3-3】Having largely ignored Covid-19 as it spread across China, global financial markets reacted strongly last week when the virus spre...

查看详情
Warren Buffett’s Berkshire Hathaway settles on its first biotech investment

【2020-2-19】Warren Buffett’s Berkshire Hathaway has bought 648,447 shares of Biogen at a combined worth of $192.4 million ahead of the ...

查看详情
Santen Forges Ophthalmology Partnerships With Verily and WHO

【2020-2-17】Santen has forged two separate partnerships with Google’s life sciences sister company Verily and the International Telecommunica...

查看详情
Glaucoma 360: Promising data as the industry considers value

【2020-2-13】“Innovation remains the largest driver of healthcare cost increase,” said David Parke II, MD, American Academy of Ophthalmology C...

查看详情

RIMONCI IN THE NEWS


Breakthrough Device Designation Received From the FDA for EndoArt®

【2020-2-5】EyeYon medical Ltd. announces Breakthrough Status Designation from the FDA for its EndoArt®, Artificial Endothelial Layer Implant.

Belkin Laser at the Glaucoma 360

【2020-1-23】At New Horizons Forum,Daria Lemann-Blumenthal, CEO of Belkin Laser, discusses the company’s clinical-stage automated 1-second las...

This Startup Cures Lazy Eye With Netflix and Disney

【2020-1-21】NovaSight’s technology treats vision disorders by letting patients watch movies on a special screen that helps train their eyes

NovaSight, a leading provider of digital healthcare platforms.

【2020-1-7】NovaSight’s prototype for vision care at CES this week. The revolutionary solution to treat amblyopia.

NEWS,Rimonci睿盟希资本,

NEWS-Rimonci睿盟希资本

NEWS,Rimonci睿盟希资本